Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Restless Legs Syndrome

fluorodeoxyglucose f18 has been researched along with Restless Legs Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leger, D; Metlaine, A; Ohnona, J; Talbot, JN1
Antonini, A; Chokroverty, S; Dhawan, V; Eidelberg, D; Hening, WA; Trenkwalder, C; Walters, AS1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and Restless Legs Syndrome

ArticleYear
A Restless Leg Syndrome Incidentally Detected by an 18F-FDG Positron Emission Tomography.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:5

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Restless Legs Syndrome

2017
Positron emission tomographic studies in restless legs syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1

    Topics: Aged; Brain; Dihydroxyphenylalanine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Receptors, Dopamine; Receptors, Presynaptic; Restless Legs Syndrome; Tomography, Emission-Computed

1999